Results 1 to 10 of about 4,518,294 (325)
Antiparasitic Properties of Cardiovascular Agents against Human Intravascular Parasite Schistosoma mansoni [PDF]
Pharmaceuticals, 2021 The intravascular parasitic worm Schistosoma mansoni is a causative agent of schistosomiasis, a disease of great global public health significance. Praziquantel is the only drug available to treat schistosomiasis and there is an urgent demand for new ...
Raquel Porto +9 more
doaj +3 more sources
Cardiovascular effects of immunosuppression agents
Frontiers in Cardiovascular Medicine, 2022 Immunosuppressive medications are widely used to treat patients with neoplasms, autoimmune conditions and solid organ transplants. Key drug classes, namely calcineurin inhibitors, mammalian target of rapamycin (mTOR) inhibitors, and purine synthesis ...
Aly Elezaby +4 more
doaj +4 more sources
Acute poisoning by cardiovascular agents [PDF]
Vojnosanitetski Pregled, 2003 In order to determine the frequency, severity of poisoning, and the efficacy of the applied therapeutic measures, retrospective study of 391 patients treated for acute drug poisoning was performed during one-year period at the Clinic for Emergency and ...
Vučinić Slavica +5 more
doaj +5 more sources
Risk of antidepressant initiation among users of cardiovascular agents and metformin. [PDF]
Pharmacology Research & Perspectives, 2023 Cardiovascular disease and diabetes are risk factors for depression, yet the relationship between the drug treatments for these diseases and the risk of antidepressant initiation remains unclear.
Ivana Bojanić +6 more
doaj +2 more sources
Pharmacology of cardiovascular chronotherapeutic agents [PDF]
American Journal of Hypertension, 2001 Although sudden cardiac death, myocardial infarction, or stroke can occur at any time of day, event rates increase during the waking hours, particularly in the morning. In most people-both normotensive and hypertensive-blood pressure (BP) rises rapidly in the early morning hours, the time when most individuals wake and begin their day.
David J. Smith
openalex +4 more sources
One Molecule, Many Faces: Repositioning Cardiovascular Agents for Advanced Wound Healing [PDF]
MoleculesChronic wound treatments pose a challenge for healthcare worldwide, particularly for the people in developed countries. Chronic wounds significantly impair quality of life, especially among the elderly.
Anna Gościniak +4 more
doaj +2 more sources
Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer’s Disease: A Narrative Review [PDF]
Annals of Geriatric Medicine and Research, 2021 While acetylcholinesterase inhibitors are used to treat a wide range of patients with Alzheimer’s disease, acetylcholinesterase inhibitor use has also been associated with a variety of cardiovascular complications, including bradycardia and syncope ...
Sara Young, Enoch Chung, Michael A. Chen
doaj +1 more source
Anatolian Journal of Cardiology, 2023 Background: Elderly comprises a specific group due to possible alterations in the effects of drugs and comorbidities. We aimed to identify for the first time the characteristics and rates regarding the inappropriate prescriptions of cardiovascular system
Mehmet Tevfik Kitapçı +5 more
doaj +1 more source
The evidence for a role of bacteria and viruses in cardiovascular disease [PDF]
Scripta Medica, 2022 Inflammation plays a critical role in atherosclerosis and cardiovascular disease. Bacteria and viruses are major causative agents of inflammation in the body which normally develops as a response to infection.
Pierce Grant N. +5 more
doaj +1 more source
Persistence and Adherence to Cardiovascular Medicines in Australia
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Background The burden of cardiovascular disease is increasing, with many people treated for multiple cardiovascular conditions. We examined persistence and adherence to medicines for cardiovascular disease treatment or prevention in Australia.
Juliana de Oliveira Costa +5 more
doaj +1 more source